Global Rx Market Will Grow 6%-7% In 2004, Roche Predicts
This article was originally published in The Pink Sheet Daily
Executive SummaryThe company expects its own performance will surpass the market growth rate.
You may also be interested in...
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.